![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 33, 31439-31448, August 17, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Unité de Physicochimie des Macromolécules
Biologiques, Institut Pasteur, CNRS URA 1773, 75724 Paris Cedex 15, France
This study presents structural parameters
associated with termination of human immunodeficiency virus, type 1 (HIV-1) reverse transcriptase (RT) at Ter2, the major termination site
located in the center of the HIV-1 genome. DNA footprinting studies of various elongation complexes formed by RT around wild type and mutant
Ter2 sites have revealed two major structural transformations of these
complexes when the enzyme gets closer to Ter2. First, the interactions
between RT and the DNA duplex are less extended, although the global
affinity of the enzyme for this duplex is only decreased by 2-fold.
Second, there is an atypical positioning of the RT RNase H domain on
the DNA duplex. We interpret our data as indicating that the
AnTm motif located upstream of Ter2 prevents a
classical positioning of the enzyme on the double-stranded part of the
DNA duplex at some precise positions of elongation downstream of this
motif. Instead, novel species of binary and/or ternary complexes,
characterized by atypical footprints, are formed. The new rate-limiting
step of the reaction, characterized in the preceding paper (Lavigne,
M., Polomack, L., and Buc, H. (2001) J. Biol. Chem.
276, 31429-31438), would be a transition leading from
these new species to a catalytically competent ternary complex.
To whom correspondence should be addressed: Dept. of Molecular
Biology, Wellman 10, Massachusetts General Hospital, Fruit St., Boston,
MA 02114. E-mail: lavigne@molbio.mgh.harvard.edu.
§
Present address: Dept of Molecular Biology, Institut Pasteur, 75724 Paris Cedex 15, France.
¶
Present address: URA 1960 CNRS, Institut Pasteur, 75724 Paris
Cedex 15, France.
This article has been cited by other articles:
![]() |
B. Marchand and M. Gotte Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase: IMPLICATIONS FOR POLYMERASE TRANSLOCATION AND DRUG RESISTANCE J. Biol. Chem., September 12, 2003; 278(37): 35362 - 35372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lavigne, L. Polomack, and H. Buc DNA Synthesis by HIV-1 Reverse Transcriptase at the Central Termination Site. A KINETIC STUDY J. Biol. Chem., August 10, 2001; 276(33): 31429 - 31438. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |